Population Pharmacokinetic Analysis of Amikacin for Optimal Pharmacotherapy in Korean Patients with Nontuberculous Mycobacterial Pulmonary Disease

Amikacin is used as a therapy for patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) who are resistant to macrolide antibiotics or have severe symptoms. This study aimed to characterize the pharmacokinetic properties of amikacin in patients with NTM-PD by developing a population p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xuanyou, Oh, Jaeseong, Cho, Joo-Youn, Lee, SeungHwan, Rhee, Su-jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694782/
https://www.ncbi.nlm.nih.gov/pubmed/33172135
http://dx.doi.org/10.3390/antibiotics9110784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694782/
https://www.ncbi.nlm.nih.gov/pubmed/33172135
http://dx.doi.org/10.3390/antibiotics9110784

Ejemplares similares